🔎 Trials Near Me

Home › Marginal Zone Lymphoma › Washington › Seattle

Marginal Zone Lymphoma clinical trials in Seattle, WA

9 studies for Marginal Zone Lymphoma are looking for participants at sites in and around Seattle (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

RecruitingPhase 1/2
  • Fred Hutchinson Cancer Research Center, Seattle
Ages 18 and older · All sexes · Updated Sep 28, 2026 · NCT05006716

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

RecruitingPhase 1
  • Swedish Cancer Institute (SCI), Seattle
Ages 18 and older · All sexes · Updated Sep 22, 2026 · NCT07101328

This is a Phase 1 Study to Evaluate the Safety of LTZ-301 in Patients With Non-Hodgkin Lymphoma

RecruitingPhase 1
  • Fred Hutchinson Cancer Center, Seattle
Ages 18 and older · All sexes · Updated Jul 24, 2026 · NCT07121946

Donor Stem Cell Transplant With Treosulfan, Fludarabine, and Total-Body Irradiation for the Treatment of Hematological Malignancies

RecruitingPhase 2Healthy volunteers welcome
  • Fred Hutch/University of Washington Cancer Consortium, Seattle
6 Months · All sexes · Updated May 29, 2026 · NCT04195633

Study of SGR-1505 in Mature B-Cell Neoplasms

RecruitingPhase 1
  • Fred Hutchinson Cancer Center, Seattle
Ages 18 and older · All sexes · Updated Feb 13, 2026 · NCT05544019

A Novel Vaccine (EO2463) as Monotherapy and in Combination, for Treatment of Patients With Indolent Non-Hodgkin Lymphoma

RecruitingPhase 1/2
  • University of Washington-Seattle Cancer Care Alliance, Seattle
Ages 18 and older · All sexes · Updated Jan 30, 2026 · NCT04669171

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

RecruitingObservational study
  • Massive Bio SYNERGY-AI site, Seattle
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774

A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies

RecruitingPhase 1
  • Swedish Cancer Institute, Seattle
Ages 18 and older · All sexes · Updated Oct 2, 2025 · NCT05780034

Marginal Zone Lymphoma trials in other cities

Other studies in Seattle

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.